In vitro disease modeling using embryonic stem cells or induced PSCs has shown considerable potential for applications in drug discovery, as well as for the elucidation of disease mechanisms 1,2.

Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment leads to significant inhibition (2-fold, ...